首页 > 市场调查报告书 > 製药

糖尿病

市场调查报告书

商品编码

1729515

日本糖尿病设备市场报告（按类型（管理设备、监测设备）、配销通路（医院药房、零售药房、糖尿病诊所/中心、线上药房等）和地区）2025 年至 2033 年

Japan Diabetes Devices Market Report by Type (Management Devices, Monitoring Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, and Others), and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024 年，日本糖尿病设备市场规模达 19.36 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 24.87 亿美元，2025-2033 年期间的成长率 (CAGR) 为 2.8%。重大创新和技术进步主要致力于满足糖尿病管理、监测和治疗的多方面需求，是推动市场成长的主要动力。

糖尿病设备是指专门设计用于管理、监测和治疗糖尿病（一种以血糖升高为特征的慢性疾病）的一类医疗设备。这些设备在帮助糖尿病患者维持最佳血糖水平和预防不受控制的糖尿病相关併发症方面发挥着重要作用。糖尿病设备包括血糖监测仪、胰岛素帮浦、胰岛素笔和持续血糖监测 (CGM) 系统等。血糖监测仪用于间歇性血糖测试，而后者提供全天的即时血糖读数。胰岛素帮浦和胰岛素笔对于胰岛素的输送至关重要，胰岛素是碳水化合物、脂肪和蛋白质代谢所必需的荷尔蒙。随着技术的进步，这些设备变得更加用户友好、准确和微创，可以满足糖尿病患者的特定需求和偏好。应用程式和远距医疗平台等数位技术的结合也有助于透过提供个人化护理和远端监控功能来更好地管理糖尿病。从本质上讲，糖尿病设备对于帮助糖尿病患者过上更健康、更容易管理的生活至关重要，可以促进医疗技术和医疗保健的进步。

日本糖尿病设备市场趋势：

日本糖尿病设备市场正经历一段大幅成长期，这受到人口老化和国内糖尿病盛行率上升等多种趋势和驱动因素的推动。由于日本拥有大量老年人口，对创新高效的糖尿病管理设备的需求比以往任何时候都更加重要，从而推动了该领域的进步和投资。人们的健康意识和糖尿病自我管理意识的增强导致对使用者友好、准确、技术先进的设备的需求增加，例如连续血糖监测系统和胰岛素输送设备。技术创新以及物联网和人工智慧的整合是市场的重要趋势，增强了糖尿病设备的功能，提供即时监控、资料分析和个人化建议，从而提高了糖尿病护理的标准。政府针对医疗创新和慢性病管理的支持政策和措施也起到了催化剂的作用，促进了市场的发展轨迹。此外，科技公司和医疗设备製造商之间的合作关係不断加强，促进了更复杂解决方案的开发。医疗保健提供者和患者对这些先进糖尿病设备的接受度和采用度不断提高，预计将进一步促进市场成长。对微创或非侵入性设备的重视以及远距医疗和远端监控的普及正在重塑日本糖尿病管理的格局，预示着该地区糖尿病设备市场前景光明。

日本糖尿病设备市场细分：

类型洞察：

管理设备
o胰岛素帮浦
o胰岛素注射器
可重复使用笔中的墨盒
o一次性胰岛素笔
oJet 喷射器
监控设备
自我监测血糖
o持续血糖监测

配销通路洞察：

医院药房
零售药局
糖尿病诊所/中心
网路药局
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。一些关键参与者包括：

爱科来株式会社
Ascensia糖尿病照护控股公司
Dexcom公司
泰尔茂株式会社

本报告回答的关键问题：

日本糖尿病设备市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本糖尿病设备市场有何影响？
日本糖尿病设备市场依类型分为哪些类型？
依照配销通路，日本糖尿病设备市场是如何分類的？
日本糖尿病设备市场的价值链分为哪些阶段？
日本糖尿病设备的主要驱动因素和挑战是什么？
日本糖尿病设备市场的结构是怎么样的？主要参与者是谁？
日本糖尿病设备市场的竞争程度如何？

本报告回答的关键问题：

日本糖尿病设备市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本糖尿病设备市场有何影响？
日本糖尿病设备市场依类型分为哪些类型？
依照配销通路，日本糖尿病设备市场是如何分類的？
日本糖尿病设备市场的价值链分为哪些阶段？
日本糖尿病设备的主要驱动因素和挑战是什么？
日本糖尿病设备市场的结构是怎么样的？主要参与者是谁？
日本糖尿病设备市场的竞争程度如何？

Japan diabetes devices market size reached USD 1,936 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,487 Million by 2033, exhibiting a growth rate (CAGR) of 2.8% during 2025-2033. Significant innovations and technological advancements, focused on addressing the multifaceted demands of diabetic management, monitoring, and treatment are primarily driving the market growth.

Diabetes devices refer to a category of medical equipment specifically designed to manage, monitor, and treat diabetes, a chronic condition characterized by elevated blood sugar levels. These devices play an essential role in assisting individuals with diabetes to maintain optimal blood glucose levels and prevent complications associated with uncontrolled diabetes. Diabetes devices include blood glucose monitors, insulin pumps, insulin pens, and continuous glucose monitoring (CGM) systems, amongst others. Blood glucose monitors are utilized for intermittent blood sugar testing, while the latter provide real-time glucose readings throughout the day. Insulin pumps and pens are crucial for the delivery of insulin, a hormone essential for the metabolism of carbohydrates, fats, and proteins. These devices, with their advancements in technology, are becoming more user-friendly, accurate, and minimally invasive, catering to the specific needs and preferences of diabetic patients. The incorporation of digital technologies such as apps and telemedicine platforms also helps in better diabetes management by offering personalized care and remote monitoring capabilities. In essence, diabetes devices are pivotal in empowering individuals with diabetes to lead a healthier and more manageable life, fostering advancements in medical technology and healthcare.

Japan Diabetes Devices Market Trends:

The Japan diabetes devices market is witnessing a period of substantial growth, driven by a confluence of trends and drivers, including an aging population and increasing prevalence of diabetes within the country. With Japan being home to a considerable elderly demographic, the necessity for innovative and efficient diabetes management devices is more paramount than ever, propelling advancements and investments in this sector. The surge in health consciousness and self-management of diabetes is leading to increased demand for user-friendly, accurate, and technologically advanced devices, such as continuous glucose monitoring systems and insulin delivery devices. Technological innovations and the integration of IoT and AI are significant trends in the market, enhancing the functionalities of diabetes devices, offering real-time monitoring, data analysis, and personalized recommendations, thus elevating the standard of diabetes care. The government's supportive policies and initiatives aimed at healthcare innovation and chronic disease management also act as catalysts, bolstering the market's trajectory. Moreover, the rise in partnerships between tech companies and medical device manufacturers is fostering the development of more sophisticated solutions. The growing acceptance and adoption of these advanced diabetes devices among healthcare providers and patients are anticipated to further augment the market growth. The emphasis on minimally invasive or non-invasive devices and the proliferation of telehealth and remote monitoring are reshaping the landscape of diabetes management in Japan, indicating a promising future for the diabetes devices market in the region.

Japan Diabetes Devices Market Segmentation:

Type Insights:

Management Devices
oInsulin Pump
oInsulin Syringes
oCartridges in Reusable Pens
oInsulin Disposable Pens
oJet Injectors
Monitoring Devices
Self-monitoring Blood Glucose
oContinuous Glucose Monitoring

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

ARKRAY Inc.
Ascensia Diabetes Care Holdings AG
Dexcom Inc.
Terumo Corporation

Key Questions Answered in This Report:

How has the Japan diabetes devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan diabetes devices market?
What is the breakup of the Japan diabetes devices market on the basis of type?
What is the breakup of the Japan diabetes devices market on the basis of distribution channel?
What are the various stages in the value chain of the Japan diabetes devices market?
What are the key driving factors and challenges in the Japan diabetes devices?
What is the structure of the Japan diabetes devices market and who are the key players?
What is the degree of competition in the Japan diabetes devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Diabetes Devices Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Diabetes Devices Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Diabetes Devices Market - Breakup by Type

6.1 Management Devices
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Insulin Pump
  - 6.1.3.2 Insulin Syringes
  - 6.1.3.3 Cartridges in Reusable Pens
  - 6.1.3.4 Insulin Disposable Pens
  - 6.1.3.5 Jet Injectors
- 6.1.4 Market Forecast (2025-2033)
6.2 Monitoring Devices
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Self-monitoring Blood Glucose
  - 6.2.3.2 Continuous Glucose Monitoring
- 6.2.4 Market Forecast (2025-2033)

7 Japan Diabetes Devices Market - Breakup by Distribution Channel

7.1 Hospital Pharmacies
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Retail Pharmacies
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Diabetes Clinics/Centers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Online Pharmacies
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Diabetes Devices Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 ARKRAY Inc.
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 Ascensia Diabetes Care Holdings AG
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Dexcom Inc.
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Terumo Corporation
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events

10 Japan Diabetes Devices Market - Industry Analysis

10.1 Drivers, Restraints and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis